Zika virus (ZIKV) is a mosquito-borne virus that has been identified as a cause of several severe disease manifestations, including congenital microcephaly and Guillain-Barré syndrome, meningoencephalitis, and myelitis. Previous studies showed that ZIKVinfected patients exhibited elevated plasma levels of interleukin 1β (IL-1β), indicating that ZIKV may activate inflammasomes. However, the molecular basis for its viral pathogenesis remains poorly understood. In this current study, we found that ZIKV infection caused severe inflammatory pathological changes and promoted IL-1β production in vitro and in vivo. We here demonstrate that the maturation and secretion of IL-1β during ZIKV infection was mediated by NLRP3 inflammasome activation and that ZIKV nonstructural protein 5 (NS5) facilitated the assembly of the NLRP3 inflammasome complex, leading to IL-1β activation through interaction with NLRP3 and induction of reactive oxygen species production. Collectively, our data identify NLRP3 inflammasomederived IL-1β production as a critical feature of inflammation during ZIKV infection. These findings offer new insights into inflammasome-mediated diseases and may provide new therapeutic options for ZIKV-associated diseases.
Zika virus (ZIKV) belongs to the family Flaviviridae (genus Flavivirus) and is transmitted by Aedes mosquitoes. Although symptomatic ZIKV infection in humans generally involves a mild, self-limited acute febrile illness associated with rash, arthralgia, and conjunctivitis, some patients develop more-severe neurological complications, such as congenital microcephaly and Guillain-Barré syndrome, meningoencephalitis, and myelitis [1] [2] [3] [4] . Recent studies have revealed an increase in the levels of proinflammatory cytokines, such as interleukin 1β (IL-1β), interferon γ (IFN-γ), interleukin 6 (IL-6), and interleukin 8 (IL-8), in ZIKV-infected patients, compared with healthy people [5] . These observations indicate that the inflammatory response may contribute to the ZIKV-associated diseases. However, the mechanisms by which ZIKV stimulates inflammatory signaling are not defined.
The proinflammatory cytokine IL-1β is a central component of the cytokine milieu and plays an important role in fever, septic shock, and inflammatory diseases. The generation of mature active IL-1β requires cleavage of the precursor, pro-IL-1β, by the inflammasome [6] . The inflammasome is a large multiprotein complex that senses infection or danger stimuli in the cell and controls the maturation and secretion of IL-1β and IL-18 [6] . Several types of inflammasomes have been identified, of which the nucleotide and oligomerization domain, leucine-rich repeat-containing protein family, pyrin-containing domain 3 (NLRP3) inflammasome is the most studied and best characterized [7] . Upon activation and oligomerization, NLRP3 interacts with the caspase-recruitment domain (CARD) molecule known as adaptor molecule apoptosis-associated speck-like protein containing CARD (ASC). Clustered ASCs in turn recruit procaspase 1 via a CARD-CARD interaction and induce the autoproteolytic conversion of the proenzyme into active caspase 1 [8] . Activated caspase 1 leads to the cleavage and release of mature IL-1β and IL-18 [9] . Activation of the NLRP3 inflammasome and IL-1β release mediate host protection against pathogen invasions. However, hyperactivation of the NLRP3 inflammasome contributes to the pathogenesis of inflammatory diseases, such as viral encephalitis and viral fulminant hepatitis [10] [11] [12] .
Activation of the NLRP3 inflammasome requires signals at both the transcriptional and posttranslational levels. The first signal leads to synthesis of pro-IL-1β and other components of the inflammasome, such as NLRP3, through the Toll-like receptor/nuclear factor κB pathway. The second signal is transduced by various pathogen-associated molecular patterns and damage-associated molecular patterns to activate the assembly of the NLRP3 inflammasome, caspase 1 activation, and IL-1β secretion [13] . Several molecular mechanisms have been indicated for NLRP3 activation to induce caspase 1 activation and IL-1β maturation. These include the generation of mitochondrial reactive oxygen species (ROS), the efflux of potassium (K + ), and the influx of calcium ions (Ca 2+ ) [14] .
In the present study, we show that mice infected with ZIKV exhibited severe inflammatory pathology and high levels of IL-1β in the serum and brain. We also show that the maturation and secretion of IL-1β during ZIKV infection was mediated by NLRP3 inflammasome activation. In addition, ZIKV nonstructural protein 5 (NS5) was identified to interact with NLRP3 and facilitate the assembly of the NLRP3 inflammasome complex and lead to IL-1β activation. Moreover, the generation of ROS was critical for NLRP3 inflammasome activation during ZIKV infection. Thus, our findings reveal the physiopathologic relevance of the NLRP3 inflammasome during ZIKV infection, which may provide therapeutic targets for anti-ZIKV treatment.
MATERIALS AND METHODS

Mice
Type I IFN receptor-deficient (Ifnar1 −/− ) mice and Nlrp3 −/− mice with the C57BL/6 background were bred in pathogen-free animal facilities at Sun Yat-Sen University (SYSU). Mice approximately 5 weeks of age were used for these experiments.
Ethics Statement
All animal studies were approved by the SYSU Institutional Animal Care and Use Committee (SYSU IACUC) under the protocol number 2017-118, and all animal experiments were performed in accordance with Animal Research: Reporting of In Vivo Experiments guidelines and guidelines approved by SYSU IACUC and were conducted in a laboratory designed to ensure biological safety.
Cell Culture
The human monocytic cell line THP-1 (purchased from the Cell Bank of the Chinese Academy of Sciences, Shanghai, China) was cultured at 37°C in 5% CO 2 in Roswell Park Memorial Institute 1640 medium supplemented with 10% fetal bovine serum (FBS; Gibco, Carlsbad, CA). THP-1 cells were differentiated into macrophages by exposure to 100 ng/mL phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich, St. Louis, MO) for 24 hours, and cells were cultured for 24 hours without PMA. 293T cells and Vero cells (both obtained from the Cell Bank of the Chinese Academy of Sciences) and 293FT cells (Invitrogen, Carlsbad, CA) were maintained at 37°C in 5% CO 2 in Dulbecco's modified Eagle's medium supplemented with 10% FBS, 2 mM L-glutamine, 100 μg/mL streptomycin, and 100 U/mL penicillin (Gibco). Aedes albopictus C6/36 cells (ATCC CRL-1660) were maintained at 28°C in 5% CO 2 in Dulbecco's modified Eagle's medium supplemented with 10% FBS. Bone marrow-derived macrophages (BMDMs) were prepared as previously described [24] and were cultured in Roswell Park Memorial Institute 1640 medium with 10% FBS and recombinant mouse macrophage colony-stimulating factor (50 ng/mL; Novus, Littleton, CO).
Virus and Infection
The Asian lineage ZIKV SZ01 strain (GenBank accession number KU866423) was amplified in C6/36 cells. For preparation of UV ray-inactivated ZIKV, the virus was dispersed in a tissue culture dish, and a compact UV lamp was placed directly above the dish for 30 minutes. Heat-inactivated ZIKV was prepared by incubating the virus at 65°C for 30 minutes to completely inhibit ZIKV activity. Virus stocks were titrated by standard plaque assays on Vero cells [25] . To inhibit caspase 1 and NLRP3 activation, cells were pretreated with AC-YVAD-CHO (Cayman Chemical, Ann Arbor, MI) and glyburide (Target Molecule, Boston, MA), respectively, for 30 minutes. The cells were then infected with ZIKV in the presence of AC-YVAD-CHO or glyburide for 1 hour at 37 ℃, washed with phosphate-buffered saline (PBS), and cultured with medium containing AC-YVAD-CHO or glyburide.
In Vivo Murine Infections
Mice were infected intraperitoneally according to a previously described method [25] . Briefly, 1 × 10 5 plaque-forming units of ZIKV in a volume of 100 μL was injected intraperitoneally into 5-week-old Ifnar1 −/− mice, which were monitored daily for morbidity and mortality. Mice with neurological changes were evaluated as previously described to assess their clinical scores, which were graded according to the severity of illness, as follows: 0 for healthy; 1 for minor illness, including weight loss, reduced mobility, and a hunchbacked body orientation; 2 for limbic seizure; 3 for moving with difficulty and anterior limb or posterior limb weakness; 4 for paralysis; and 5 for death [26] .
Histological Analysis
Mouse brain tissues were harvested and fixed in 4% paraformaldehyde for 24 hours at room temperature. The fixed tissues were dehydrated, embedded in paraffin, sectioned, rehydrated, and stained with hematoxylin and eosin (H/E). The H/E-stained sections were evaluated for viral-induced neuropathology.
Plasmid Construction
The lentivirus vector pSin4-EF2-IRES-Pur was modified by introducing certain restriction enzyme cutting sites (BamHIEcoRI-BstbI-NdeI-NheI-SpeI) into the multiple cloning site. To generate lentiviruses expressing Flag-tagged ZIKV C, prM, E, NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5 proteins, the fulllength complementary DNA encoding each viral protein was amplified by reverse-transcription polymerase chain reaction (RT-PCR) analysis and cloned into the pSin4-EF2-IRES-Pur vector. A plasmid encoding human NLRP3 with an N-terminal Myc epitope tag was amplified by RT-PCR and cloned into the KpnI and XbaI sites of the pcDNA3.1 vector. Full-length ZIKV NS5 and its truncated forms, the methyltransferase domain and the RNA-dependent RNA polymerase (RdRp) domain, with N-terminal 6×His epitope tags were amplified by PCR and cloned into the KpnI and XbaI sites of the pcDNA3.1 vector. All constructs were verified by DNA sequencing.
Lentivirus Production and Infection
For virus production, a pSin4-EF2-IRES-Pur vector encoding each viral protein was transfected into 293FT cells together with the packaging plasmid psPAX2 and the envelope-coding plasmid pMD2.G, using Lipofectamine 3000 (Invitrogen) according to the manufacturer's protocol. Forty-eight hours after transfection, the supernatants were collected, centrifuged at 500×g for 10 minutes, and filtered through 0.45-μm filters. Cells were infected overnight with the supernatants containing lentiviral particles. Culture supernatants were collected 24 hours after infection and assayed for IL-1β by an enzyme-linked immunosorbent assay (ELISA).
ELISA
Concentrations of human and murine cytokines were determined according to the manufacturers' instructions with following ELISA kits from eBiosciences (San Diego, CA), for IL-1β and IL-18; Raybiotech (Norcross, GA), for TNF-α and IL-6; and R&D Systems (Minneapolis, MN), for monocyte chemoattractant protein 1.
Western Blotting
Tissue specimens obtained from mouse brains or cells were lysed with RIPA lysis buffer (Millipore, Bedford, MA) containing a cocktail of protease and phosphatase inhibitors (SigmaAldrich). Protein samples were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred onto a polyvinylidene difluoride membrane. The membranes were probed with the following primary antibodies: anti-IL-1β, anti-NLRP3, and anti-caspase 1 (all from Cell Signaling, Danvers, MA); anti-ZIKV envelope protein and anti-ZIKV NS5 (both from BioFront Technologies, Tallahassee, FL); anti-ASC (Santa Cruz Biotechnology, Dallas, TX); anti-human β-actin (Sigma-Aldrich). Membranes were incubated with horseradish peroxidase-conjugated secondary antibodies, and signals were detected by enhanced chemiluminescence, using a commercial kit (Thermo Fisher Scientific, Rockford, IL) according to the manufacturer's suggested protocols.
ASC Oligomerization Detection
ASC pyroptosomes were detected as previously reported [27] . Briefly, cells were pelleted by centrifugation and resuspended in 0.5 mL of ice-cold buffer containing 50 mM Tris (pH 7.5), 150 mM NaCl, 1% NP40, 5 mM ethylenediaminetetraacetic acid (EDTA), and 10% glycerol. The cell lysates were then centrifuged at 6000×g for 15 minutes at 4°C, and the supernatants were mixed with sodium dodecyl sulfate loading buffer for Western blotting. The pellets were washed 3 times with PBS and resuspended in 500 μL of PBS. Next, the resuspended pellets were cross-linked with fresh disuccinimidyl suberate (4 mM; Sigma-Aldrich) at 37°C for 30 minutes. The cross-linked samples were then centrifuged and mixed with sodium dodecyl sulfate loading buffer for Western blotting.
Viral RNA Isolation and Transfection
Viral RNA was extracted from the supernatant of ZIKVinfected or mock-infected C6/36 cells 48 hours after infection, using a QIAamp Viral RNA Kit (Qiagen, Hilden, Germany). The concentration of the viral RNA was determined by a NanoDrop spectrophotometer (Thermo Fisher Scientific). PMA-differentiated human THP-1 macrophages were transfected with RNA from infected or mock-infected C6/36 cells or with poly(dA:dT) (10 μg/mL; Invivogen, San Diego, CA) using Lipofectamine 3000 (Invitrogen). The concentrations of IL-1β in the cell-free supernatants were measured 24 hours after transfection.
Small Interfering RNA (siRNA) Synthesis and Transfection
Control siRNA and gene-specific siRNAs were purchased from RiBoBio (Guangzhou, China). The targeting sequences of siRNA for human NLRP3, ASC, and caspase 1 were CAGGTTTGACTATCTGTTCT, GATGCGGAAGCTCTT CAGTTTCA, and GTGAAGAGATCCTTCTGTA, respectively. The siRNA was delivered into the cells by using Lipofectamine 3000 transfection reagent (Invitrogen).
Measurement of ROS Production
Intracellular ROS levels were measured by staining cells with 5-(and-6)-chloromethyl-2' ,7'-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) dye (Sigma-Aldrich). An ROS inhibitor, diphenyleneiodonium chloride (DPI; Sigma-Aldrich), was used as the control. Briefly, cells were incubated with or without 1 μM DPI for 4 hours, followed by vector-virus infection. Twenty-four hours after challenge, the cells were stained with a solution containing CM-H2DCFDA dye (5 μM). Cells were then observed under a Zeiss Axio Imager Z2 microscope and analyzed with ZEN software (Carl Zeiss MicroImaging, Jena, Germany).
Coimmunoprecipitation Assay
293T cells transfected with vector plasmids were lysed with protein lysis buffer containing 25 mM HEPES, 150 mM NaCl, 1 mM EDTA, 2% glycerol, 1% NP40, and a cocktail of protease and phosphatase inhibitors (Sigma-Aldrich). Lysates were incubated with the anti-His antibody (Abcam, Cambridge, MA) or mouse immunoglobulin G antibody overnight at 4°C. Subsequently, precipitates were washed 5 times with wash buffer containing 20 mM HEPES, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 2% glycerol, and 0.1% NP-40; resuspended in sampling buffer; and examined by Western blotting.
Statistical Analyses
The results are expressed as mean values (±standard deviations). Statistical analyses were performed on triplicate experiments, using a 2-tailed Student t test.
RESULTS
ZIKV Infection Causes Severe Pathology That Precedes Lethality in Mice
To study the interplay between ZIKV and the host immune system, we used Ifnar1 −/− mice to generate a ZIKV infection model in vivo. ZIKV was injected intraperitoneally into 5-week-old mice. The survival rate in the ZIKV-infected mice was 33% on day 8 after infection, and all the mice died by day 9 after infection ( Figure 1A ). In addition, during ZIKV infection, significant loss of body weight occurred by day 5 after infection ( Figure 1B) . Moreover, mice infected with ZIKV developed neurological disease symptoms, including lethargy, hunched posture, hind limb weakness, and paralysis ( Figure 1C) , and high viral loads were noted, indicating a strong neurotropism of ZIKV ( Figure 1D ). Histopathological examination showed diffuse meningeal infiltration by a mixture of neutrophils and mononuclear cells in the cerebrum. Several perivascular cuffs of mononuclear cells, microglial cells, and vasculitis were widely observed in the neuropil of the cerebral cortex (Figure 2 ). These findings indicate progressive meningoencephalitis caused by ZIKV infection. 
ZIKV Infection Induces IL-1β Secretion In Vivo and In Vitro
We next examined whether the proinflammatory cytokines were induced by ZIKV infection. Notably, a significant increase in IL-1β levels was observed in both brain tissue and serum samples from infected mice ( Figure 3A and B). In addition, the levels of IL-6, IL-18, TNF-α, and monocyte chemoattractant protein 1 were also assessed in both sample types (Supplemental Figure 1) . Because IL-1β is a central component of the cytokine milieu and plays an important role in many immune reactions, we next used PMA-differentiated human THP-1 macrophages to verify the induction of IL-1β production by ZIKV infection. As shown in Figure 3C , the amount of IL-1β secretion increased in a multiplicity of infection-dependent manner. Lipopolysaccharide (LPS)/ ATP stimuli served as a positive control in these experiments. Furthermore, time-course assays showed increased IL-1β secretion ( Figure 3D) . Overall, the above results indicated that ZIKV infection induces IL-1β production both in vivo and in vitro.
NLRP3 Inflammasome Is Involved in ZIKV-Induced IL-1β Secretion
Previous studies have demonstrated that IL-1β maturation and secretion are mediated by cleavage of caspase 1 under the control of the inflammasome [6] . We next determined the direct indicators of inflammasome activation, caspase 1 cleavage and ASC pyroptosome formation, in ZIKV-infected cells. As shown in Figure 4A , there was a ZIKV-induced increase in cleaved caspase 1 levels and mature IL-1β levels. An ASC oligomer was formed after ZIKV infection ( Figure 4A ). LPS/ATP stimuli served as a positive control in these experiments. Moreover, we observed that the caspase 1 inhibitor AC-YVAD-CHO and the NLRP3 inhibitor glyburide significantly reduced ZIKVinduced IL-1β production, suggesting that ZIKV-induced IL-1β production was dependent on caspase 1 and NLRP3 ( Figure 4B ). The above results were further confirmed by using siRNAs to silence the expression of NLRP3, ASC, and caspase 1 in cells before ZIKV infection ( Figure 4C) . Moreover, mouse BMDMs deficient for NLRP3 exhibited decreased secretion of IL-1β, compared with wild-type cells, when infected with ZIKV ( Figure 4D ). Western blotting confirmed knockdown of genes encoding NLRP3, ASC, and caspase 1 and knockout of NLRP3 at the protein level (Supplementary Figure 2) . Together, these data suggest that ZIKV infection activates the NLRP3 inflammasome and that the activity of NLRP3 is required for ZIKVinduced IL-1β secretion.
ZIKV NS5 Is Sufficient to Trigger Inflammasome Activation
We next investigated whether viral replication is required for NLRP3 inflammasome activation by ZIKV. As shown in Figure 5A , UV ray-or heat-inactivated ZIKV failed to induce IL-1β secretion from THP-1 macrophages, indicating that ZIKV replication is required to activate the NLRP3 inflammasome. Additionally, we stimulated cells with control RNA, ZIKV genomic RNA, and, as a positive control, poly(dA:dT). The investigation showed that ZIKV genomic RNA transfection failed to induce IL-1β production ( Figure 5A ). To further determine whether the ZIKV protein activated the NLRP3 inflammasome, we transduced THP-1 macrophages with lentiviruses expressing the 10 ZIKV proteins separately. We found that IL-1β was significantly induced by NS5 but not by the other proteins tested ( Figure 5B ). Moreover, we found that THP-1 macrophages transduced with the NS5-expressing lentivirus triggered an increase in cleaved caspase 1 levels and mature IL-1β levels ( Figure 5C ) and the formation of ASC oligomer ( Figure 5D ). LPS/ATP stimulation served as a positive control in these experiments. Thus, these findings indicate that the expression of ZIKV NS5 is sufficient to activate the NLRP3 inflammasome.
ZIKV NS5 Binds with NLRP3 Through Its RdRp Domain
Further, we examined whether ZIKV NS5 could induce IL-1β secretion in Nlrp3 −/− cells. As shown in Figure 6A , lentivirus expressing ZIKV NS5 triggered an increase of IL-1β secretion in BMDMs of C57BL/6 WT mice but not in those of Nlrp3 −/− mice. We next performed coimmunoprecipitation assays to investigate whether ZIKV NS5 activates the NLRP3 inflammasome through interaction with NLRP3. We observed that ZIKV NS5 bound to NLRP3 ( Figure 6B ). To further map the NS5 domains involved in NLRP3 binding, we generated constructs that contain the methyltransferase domain and the RdRp domain of NS5. Our coimmunoprecipitation assays showed that RdRp could pull down NLRP3 ( Figure 6C ), suggesting that ZIKV NS5 interacts with NLRP3 through its RdRp domain.
ROS Generation Is Required for ZIKV-Driven Maturation of IL-1β
As previously reported, one widely acknowledged mechanism mediating the activation of NLRP3 inflammasome is mitochondrial ROS production. ROS production by mitochondria leads to the dissociation of thioredoxin (TRX) from TRX-interacting protein, which associates with NLRP3 to facilitate inflammasome formation [15] . We therefore investigated whether the ROS production is required for inflammasome activation during ZIKV infection. As shown in Figure 7A , ZIKV infection increased ROS production in a multiplicity of infection-dependent manner. By contrast, treatment with DPI, a potent ROS inhibitor, significantly decreased ZIKV-induced ROS levels and IL-1β production ( Figure 7A and B) . Moreover, we found that cells transduced with the NS5-expressing lentivirus triggered an increase in ROS production ( Figure 7C ). These data suggest that the generation of ROS during ZIKV infection might act as a stress signal for inflammasome activation, which in turn is crucial for IL-1β production.
DISCUSSION
The main finding of our present study is that ZIKV, a positive-strand RNA virus, triggers NLRP3 inflammasome-mediated IL-1β production by interacting with NLRP3 and inducing ROS generation through the action of the virus-encoded NS5 protein. (Figure 7D ). Our data reveal the physiopathologic relevance of the NLRP3 inflammasome during ZIKV infection, which may provide therapeutic targets along these pathways for novel anti-ZIKV treatment. ZIKV has been recognized to cause more-severe neurological complications, such as congenital microcephaly and GuillainBarré syndrome, meningoencephalitis, and myelitis [1] [2] [3] [4] .
Recent studies have revealed an increase in the levels of IL-1β in ZIKV-infected patients and human primary microglia cells infected with ZIKV [5, 16] . Because IL-1β has been implicated in neuroinflammation associated with several neurological diseases, including viral encephalitis, Parkinson disease, and Alzheimer disease [10, [17] [18] [19] , understanding the pathway leading to IL-1β secretion may be valuable for developing therapies to reduce neuroinflammation and neurological diseases.
NLRP3 inflammasomes are multiprotein complexes that mediate the activation of caspase 1, which promotes the secretion of the proinflammatory cytokines IL-1β and IL-18. Previous studied have revealed that a variety of viruses can activate the NLRP3 inflammasome, including influenza virus, Japanese encephalitis virus, encephalomyocarditis virus, human immunodeficiency virus type 1, and enterovirus 71 [11, 17, [20] [21] [22] . We report here that ZIKV also activates the NLRP3 inflammasome, leading to the cleavage of caspase 1 and the release of IL-1β. In addition, we further demonstrate that UV ray-or heat-inactivated ZIKV failed to induce IL-1β secretion, indicating that ZIKV replication is required to activate the NLRP3 inflammasome. Viral proteins, such as human immunodeficiency virus type 1 Vpr, encephalomyocarditis virus 2B, and enterovirus 71 3D proteins, play a stimulatory role in the regulation of the NLRP3 inflammasome [21] [22] [23] . In this study, we identified that the ZIKV NS5 protein is sufficient to activate the NLRP3 inflammasome. Our results demonstrated that ZIKV NS5 could promote NLRP3 inflammasome activation by interacting with NLRP3. Our work extends the functions of NS5 by showing that it plays a role in regulating the NLRP3 inflammasome and IL-1β production. Activation of the NLRP3 inflammasome requires a posttranscriptional signal that is transduced by a wide range of pathogen-associated molecular patterns and damage-associated molecular patterns. Several molecular mechanisms have been implicated in NLRP3 activation, including production of ROS from damaged mitochondria. In this study, we report that ZIKV infection or NS5 expression triggers an increase in ROS production. However, treatment of ROS inhibitor significantly decreased ZIKV-induced ROS levels. These data indicate that the generation of ROS during ZIKV infection might act as a stress signal for inflammasome activation, which in turn is crucial for IL-1β production. Further investigation of how NS5 promotes ROS production is warranted.
In summary, the current study shows that ZIKV infection triggers severe inflammatory pathology and high levels of IL-1β in vivo. We also show that the maturation and secretion of IL-1β during ZIKV infection is mediated by NLRP3 inflammasome activation. ZIKV NS5 protein was found to facilitate the assembly of the NLRP3 inflammasome complex and lead to IL-1β activation through binding NLRP3 and inducing ROS production. These results reveal a novel mechanism for the ZIKV-mediated inflammatory response, which may provide therapeutic targets along these pathways for novel strategies to treat ZIKV-associated diseases.
Supplementary Data
Supplementary materials are available at The Journal of Infectious Diseases online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author. 
